Ketoacidosis with SGLT2 inhibitors in Denmark over 20 years

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2017年 / 1644卷 / 1期
关键词：
D O I：
10.1007/s40278-017-27783-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 11
相关论文
共 50 条
  • [31] A case series of diabetic ketoacidosis associated with SGLT2 inhibitors
    Zac-Varghese, Sagen
    Mathew, Sunitha
    Go, Daniel
    Winocour, Peter
    PRACTICAL DIABETES, 2023, 40 (03) : 21 - +
  • [32] DIABETES SGLT2 inhibitors and diabetic ketoacidosis - a growing concern
    Umpierrez, Guillermo E.
    NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (08) : 441 - 442
  • [33] SGLT2 inhibitors increase risk of genital infections and ketoacidosis
    Reactions Weekly, 2021, 1853 (1) : 10 - 10
  • [34] FEARS study: SGLT2 inhibitors associated with ketoacidosis risk
    Hamann, Andreas
    DIABETOLOGIE UND STOFFWECHSEL, 2018, 13 (02) : 138 - +
  • [35] NOT SO SWEET: EUGLYCEMIC DIABETIC KETOACIDOSIS AND SGLT2 INHIBITORS
    Simonson, Michael G.
    Omran, Sina Salehi
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S524 - S524
  • [36] SGLT2 Inhibitors Use and Diabetic Ketoacidosis in the Inpatient Setting
    Zankar, Sarah
    Arnaout, Amel
    DIABETES, 2023, 72
  • [37] Beware Ketoacidosis with SGLT2 Inhibitors in Latent Autoimmune Diabetes of the Adult
    Nolan, Brendan J.
    Varadarajan, Suresh
    Fourlanos, Spiros
    Neoh, Sandra L.
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (08): : E422 - E424
  • [38] Rate of diabetic ketoacidosis higher with new use of SGLT2 inhibitors
    Reactions Weekly, 2021, 1874 (1) : 11 - 11
  • [39] The comparative safety of individual SGLT2 inhibitors and the risk of diabetic ketoacidosis
    Abrahami, Devin
    D'Andrea, Elvira
    Kim, Seoyoung
    Wexler, Deborah
    Paik, Julie
    Patorno, Elisabetta
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 115 - 115
  • [40] Evolving Clinical Features of Diabetic Ketoacidosis: The Impact of SGLT2 Inhibitors
    Genc, Selin
    Evren, Bahri
    Yigit, Onur Selcuk
    Sahin, Ibrahim
    Dayanan, Ramazan
    Klisic, Aleksandra
    Erturk, Ayse
    Mercantepe, Filiz
    PHARMACEUTICALS, 2024, 17 (11)
12345